GTS Securities’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
BBA
GTS Securities's KYMR Position: Q3 2026 in Review
GTS Securities opened a new position in Kymera Therapeutics (KYMR) in Q3 2026: 1,939 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #1490 among its holdings.
301 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.
- GTS Securities held 1,939 shares of Kymera Therapeutics worth $217K as of Q3 2026.
- Kymera Therapeutics was a new GTS Securities position in Q3 2026.
- Kymera Therapeutics made up ﹤0.01% of GTS Securities's portfolio in Q3 2026, its #1490 holding.
- 301 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.
Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.